ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,751.07
      0.90%
      US Tech 100
      19,476.00
      1.10%
      Dow Jones
      42,352.75
      0.81%
      Brent Oil
      77.97
      0.00%
      Bitcoin
      62,221.20
      0.24%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Cullinan Therapeutics Inc (CGEM) Quote

      Cullinan Therapeutics Inc

      Cullinan Therapeutics Inc (CGEM)

      NASDAQ
      16.34
      0.24
      (1.49%)
      Closed October 05 4:00PM
      Delayed by 15 minutes
      16.32
      -0.02
      (-0.12%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      16.34
      Bid
      15.00
      Ask
      17.60
      Volume
      220,869
      16.175 Day's Range 16.4822
      7.64 52 Week Range 30.1886
      Market Cap
      947.338M
      Previous Close
      16.10
      Open
      16.40
      Last Trade
      21700
      @
      16.34
      (priorref)
      Last Trade Time
      Financial Volume
      $ 3,601,603
      VWAP
      16.3065
      Average Volume (3m)
      664,426
      Shares Outstanding
      57,976,641
      Dividend Yield
      -
      PE Ratio
      -6.18
      Earnings Per Share (EPS)
      -2.64
      Revenue
      -
      Net Profit
      -153.16M

      About Cullinan Therapeutics Inc

      Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients. Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.cullinantherapeutics.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Cullinan Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker CGEM. The last closing price for Cullinan Therapeutics was $16.10. Over the last year, Cullinan Therapeutics shares have traded in a share price range of $ 7.64 to $ 30.1886.

      Cullinan Therapeutics currently has 57,976,641 shares outstanding. The market capitalization of Cullinan Therapeutics is $933.42 million. Cullinan Therapeutics has a price to earnings ratio (PE ratio) of -6.18.

      Ask ADVFN Intelligence (AI)

      CGEM Latest News

      More News

      Form 8-K - Current report

      September 17 2024
      Edgar (US Regulatory)

      Cullinan Therapeutics Receives Approval to Initiate its Global Phase 1 Clinical Trial of CLN-978 for the Treatment of Systemic Lupus Erythematosus

      Phase 1 clinical trial is designed to assess the safety, pharmacokinetics and initial clinical activity of CLN-978 for patients with systemic lupus erythematosus The trial will be conducted in...

      September 17 2024
      GlobeNewswire Inc.

      Cullinan Therapeutics Announces Submission of Investigational New Drug Application to U.S. Food and Drug Administration for CLN-978 to Treat Systemic Lupus Erythematosus

      CAMBRIDGE, Mass., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today...

      September 16 2024
      GlobeNewswire Inc.

      Cullinan Therapeutics Presents Positive Updated Data from Module C of Zipalertinib Pivotal Phase 2b Study at ESMO 2024

      Updated data show consistent objective response rate of 40% and manageable safety profile in patients with non-small cell lung cancer harboring epidermal growth factor receptor exon 20 insertion...

      September 14 2024
      GlobeNewswire Inc.

      Form 4 - Statement of changes in beneficial ownership of securities

      September 09 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      September 05 2024
      Edgar (US Regulatory)

      Cullinan Therapeutics to Participate in Upcoming Investor Conferences

      CAMBRIDGE, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company focused on developing modality-agnostic targeted...

      August 28 2024
      GlobeNewswire Inc.

      Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results

      Investigational New Drug (IND) application for CLN-978 in systemic lupus erythematosus (SLE) remains on track to be filed in third quarter of 2024 Company to pursue rheumatoid arthritis (RA) as...

      August 08 2024
      GlobeNewswire Inc.

      Form EFFECT - Notice of Effectiveness

      June 05 2024
      Edgar (US Regulatory)

      Form 424B3 - Prospectus [Rule 424(b)(3)]

      June 04 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-1.16-6.6285714285717.517.716515.840903016.67765338CS
      4-1.5-8.4080717488817.8418.619915.867003417.44499055CS
      12-0.04-0.244200244216.3821.0115.766442617.95517801CS
      26-0.99-5.7126370455917.3330.188615.281662420.01914911CS
      528.24101.7283950628.130.18867.6456412018.36369115CS
      156-8.2-33.414832925824.5430.18867.336229215.51850954CS
      260-25.66-61.09523809524259.857.334312918.22883407CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CHSNChanson International Holding
      $ 11.22
      (269.08%)
      		14.76M
      PEVPhoenix Motor Inc
      $ 1.0607
      (205.24%)
      		228.42M
      ENTOEntero Therapeutics Inc
      $ 0.60
      (72.20%)
      		10.42M
      BENFBeneficient
      $ 1.8914
      (58.94%)
      		108.31M
      FORDForward Industries Inc
      $ 5.3254
      (52.15%)
      		18.45M
      ADDColor Star Technology Company Ltd
      $ 0.2701
      (-39.98%)
      		15.01M
      DUOFangDD Network Group Ltd
      $ 2.53
      (-32.89%)
      		28.52M
      ICCTiCoreConnect Inc
      $ 0.4102
      (-31.50%)
      		1.68M
      ZENAZenaTech Inc
      $ 3.91
      (-29.55%)
      		213.24k
      SPAISafe Pro Group Inc
      $ 1.93
      (-25.77%)
      		239.89k
      NVDANVIDIA Corporation
      $ 124.92
      (1.68%)
      		244.46M
      PEVPhoenix Motor Inc
      $ 1.0607
      (205.24%)
      		228.42M
      SQQQProShares UltraPro Short QQQ
      $ 7.43
      (-3.63%)
      		184.47M
      NCNCnoco noco Inc
      $ 0.144
      (8.60%)
      		147.38M
      BENFBeneficient
      $ 1.8914
      (58.94%)
      		108.31M

      CGEM Discussion

      View Posts
      Monksdream Monksdream 3 weeks ago
      CGEM range bound

      👍️0
      Monksdream Monksdream 5 months ago
      CGEM new 52 week high
      👍️0

      Your Recent History

      NASDAQ
      CGEM
      Cullinan Therapeutics
      BIT
      L91733
      Credit Agricole
      Delayed Upgrade Clock